IMR Press / RCM / Volume 2 / Issue 2 / pii/1561516061087-25771875

Reviews in Cardiovascular Medicine (RCM) is published by IMR Press from Volume 19 Issue 1 (2018). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with MedReviews, LLC.

Open Access Case Review
Percutaneous Transluminal Septal Myocardial Ablation: A Novel, Nonsurgical Treatment for Symptomatic Hypertrophic Cardiomyopathy
Show Less
1 Cedars-Sinai Medical Center, Los Angeles, CA
Rev. Cardiovasc. Med. 2001, 2(2), 97–102;
Published: 30 June 2001
Abstract
Patients with severely symptomatic hypertrophic obstructive cardiomyopathy (HOCM) have several alternatives when drugs do not help. Surgical septal myotomymyectomy, though effective, is an open-heart surgical procedure and can be associated with some complications. The less invasive dual chamber pacing has not lived up to its early promise. Percutaneous transluminal septal myocardial ablation (PTSMA) is a relatively simple, less complicated nonsurgical procedure that can provide an effective and sustained relief of left ventricular outflow tract (LVOT) obstruction. Should it gain wider acceptance?
Keywords
Hypertrophic obstructive cardiomyopathy
Percutaneous transluminal septal myocardial ablation
Chemical myomectomy
Surgical septal myotomymyectomy
Dual-chamber pacing
Share
Back to top